Could a nasal spray help stroke patients heal? new trial launches
NCT ID NCT07398612
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests a nasal spray made from human stem cell exosomes in 60 people who recently had a stroke. The spray is given once or daily for 14 days, alongside standard care. The main goal is to see if it is safe, and researchers will also check if it helps improve brain function and reduce damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Human adipose-derived stem cell exosomes (nasal spray)
What this could lead to
If it works, this could point toward a new way to help people recover from stroke without surgery or strong drugs.
What could go wrong
This is an early Phase 1/2 trial with only 60 people, so it is mainly checking safety. The treatment may not improve recovery, and side effects are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••